特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
936417

CRISPR技術: 世界市場

CRISPR Technology: Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 83 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
CRISPR技術: 世界市場
出版日: 2020年05月08日
発行: BCC Research
ページ情報: 英文 83 Pages
納期: 即納可能 即納可能とは
担当者のコメント
新たなゲノム編集技術のツールとして、今後2023年度までには全世界でおおよそ20兆円の市場規模が見込まれるCRISPR技術の市場に着目した調査レポートが、米国BCC Researchよりリリースされました。エンドユーザー別、アプリケーション別に市場データは区分されており、技術概要、市場データと広くまとまった調査レポートといえます。約100ページ程度の内容になり、オンラインでまずは全体構成をご案内させていただきますので、お問合せ下さい。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

CRISPR技術の世界の市場は、2018年の750億米ドルから2023年までに2189億米ドルに成長すると予測され、2018年から2023年間の複合年間成長率(CAGR)は23.9%が見込まれています。

当レポートでは、世界のCRISPR技術市場について調査し、市場概要、規制環境、各セグメントおよび地域別によるの市場分析と予測、市場発展への影響要因、競合環境、および主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

  • 研究の目標と目的
  • 調査理由
  • レポートの範囲
  • 情報源
  • 調査手法
  • 地理的な内訳
  • アナリストの経歴
  • BCCカスタム調査
  • BCC Research 関連レポート

第2章 まとめとハイライト

第3章 市場概要

  • CRISPR:遺伝子編集
  • 遺伝子編集の長所
  • CRISPR開発段階
  • CRISPRの発見
  • Cas9とPAMの発見
  • 仮説:適応免疫
  • 適応免疫
  • スペーサー配列:gRNA
  • CRISPRはDNAをターゲットに作用
  • Cas9はターゲットDNAを切断
  • Cas9システム用のtracrRNA
  • 他の種のCRISPRシステム
  • Cas9を介した切断
  • CRISPR-Cas9:ゲノム編集
  • 市場潜在性
  • 規制の枠組み
  • 米国の規制と監視
  • NIHガイドライン
  • 米国FDA
  • 倫理的配慮
  • 規制上の問題
  • 人間の生殖細胞の編集の規制
  • 世界の規制
  • ポーターのファイブフォース分析
  • 特許分析
  • CRISPRテクノロジーの知的財産(IP)とライセンス構造の概要
  • 業界成長要因
  • CRISPR vs. 疾患
  • 政府の資金
  • 他の分野におけるCRISPR
  • 業界の制約
  • 代替技術
  • 業界の課題
  • 特許問題

第4章 業界構造

  • 商業的な治療
  • 遺伝的エラーの修正
  • 微生物
  • 健康的な食品

第5章 競合情勢

  • Cellectis
  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Sangamo Therapeutics

第6章 CRISPR技術の世界市場:エンドユーザー別

  • 学術機関
  • 研究開発機関
  • 製薬会社
  • バイオテクノロジー企業

第7章 CRISPR技術の世界市場:アプリケーション別

  • 細胞株工学
  • CRISPRプラスミド
  • 遺伝子工学
  • GRNAデータベース/遺伝子ライブラリ
  • ヒト幹細胞

第8章 CRISPR技術の世界市場:地域別

  • 北米
  • 米国
  • 欧州
  • 英国
  • アジア太平洋
  • 中国
  • インド
  • その他の地域

第9章 企業プロファイル

  • CARIBOU BIOSCIENCES
  • CRISPR THERAPEUTICS
  • EDITAS MEDICINE
  • GENSCRIPT
  • HORIZON DISCOVERY PLC
  • INTEGRATED DNA TECHNOLOGIES
  • INTELLIA THERAPEUTICS INC.
  • LONZA GROUP LTD.
  • NEW ENGLAND BIOLABS INC.
  • ORIGENE TECHNOLOGIES
  • PRECISION BIOSCIENCES
  • SANGAMO THERAPEUTICS INC.
  • THERMO FISHER SCIENTIFIC
  • TRANSPOSAGENBIO BIOPHRAMACEUTICALS(HERA BIOLABS)
図表

List of Tables

  • Summary Table : Global Market for CRISPR Technology, by End User, Through 2023
  • Table 1 : Selected Monogenic Disease Details
  • Table 2 : CRISPR Application
  • Table 3 : Selected CAR-T/Gene-Editing Collaborations
  • Table 4 : CRISPR Technology: Selected Companies
  • Table 5 : CRISPR Technology: Selected Mergers and Acquisitions
  • Table 6 : CRISPR Technology: Selected Joint Ventures
  • Table 7 : CRISPR Technology: Recent Developments
  • Table 8 : CRISPR Technology: Competitive Scenario
  • Table 9 : Global Market for CRISPR Technology Used by Academic Institutes, Through 2023
  • Table 10 : Global Market for CRISPR Technology Used by Academic Institutes, by Region, Through 2023
  • Table 11 : Global Market for CRISPR Technology Used by R&D Institutes, Through 2023
  • Table 12 : Global Market for CRISPR Technology Used by R&D Institutes, by Region, Through 2023
  • Table 13 : Global Market for CRISPR Technology Used by Pharmaceutical Companies, Through 2023
  • Table 14 : Global Market for CRISPR Technology Used by Pharmaceutical Companies, by Region, Through 2023
  • Table 15 : Global Market for CRISPR Technology Used by Biotechnology Companies, Through 2023
  • Table 16 : Global Market for CRISPR Technology Used by Biotechnology Companies, by Region, Through 2023
  • Table 17 : Global Market for CRISPR Technology, by Application, Through 2023
  • Table 18 : Global Market for CRISPR Technology in Cell Line Engineering Applications, Through 2023
  • Table 19 : Global Market for CRISPR Technology in Cell Line Engineering Applications, by Region, Through 2023
  • Table 20 : Global Market for CRISPR Technology in Plasmid Applications, Through 2023
  • Table 21 : Global Market for CRISPR Technology in Plasmid Applications, by Region, Through 2023
  • Table 22 : Global Market for CRISPR Technology in Genetic Engineering Applications, Through 2023
  • Table 23 : Global Market for CRISPR Technology in Genetic Engineering Applications, by Region, Through 2023
  • Table 24 : Global Market for CRISPR Technology in GRNA Database/Gene Library Applications, Through 2023
  • Table 25 : Global Market for CRISPR Technology in GRNA Database/Gene Library Applications, by Region, Through 2023
  • Table 26 : Global Market for CRISPR Technology in Human Stem Cell Applications, Through 2023
  • Table 27 : Global Market for CRISPR Technology in Human Stem Cell Applications, by Region, Through 2023
  • Table 28 : Global Market for CRISPR Technology, by Region, Through 2023
  • Table 29 : North American Market for CRISPR Technology, Through 2023
  • Table 30 : North American Market for CRISPR Technology, by End User, Through 2023
  • Table 31 : North American Market for CRISPR Technology, by Application, Through 2023
  • Table 32 : U.S. Market for CRISPR Technology, Through 2023
  • Table 33 : U.S. Market for CRISPR Technology, by End User, Through 2023
  • Table 34 : U.S. Market for CRISPR Technology, by Application, Through 2023
  • Table 35 : European Market for CRISPR Technology, Through 2023
  • Table 36 : European Market for CRISPR Technology, by End User, Through 2023
  • Table 37 : European Market for CRISPR Technology, by Application, Through 2023
  • Table 38 : UK Market for CRISPR Technology, Through 2023
  • Table 39 : UK Market for CRISPR Technology, by End User, Through 2023
  • Table 40 : UK Market for CRISPR Technology, by Application, Through 2023
  • Table 41 : Asia-Pacific Market for CRISPR Technology, Through 2023
  • Table 42 : Asia-Pacific Market for CRISPR Technology, by End User, Through 2023
  • Table 43 : Asia-Pacific Market for CRISPR Technology, by Application, Through 2023
  • Table 44 : Chinese Market for CRISPR Technology, Through 2023
  • Table 45 : Chinese Market for CRISPR Technology, by End User, Through 2023
  • Table 46 : Chinese Market for CRISPR Technology, by Application, Through 2023
  • Table 47 : Indian Market for CRISPR Technology, Through 2023
  • Table 48 : Indian Market for CRISPR Technology, by End User, Through 2023
  • Table 49 : Indian Market for CRISPR Technology, by Application, Through 2023
  • Table 50 : Rest of the World Market for CRISPR Technology, Through 2023
  • Table 51 : Rest of the World Market for CRISPR Technology, by End User, Through 2023
  • Table 52 : Rest of the World Market for CRISPR Technology, by Application, Through 2023
  • Table 53 : Caribou Biosciences: Product Portfolio
  • Table 54 : Caribou Biosciences: Recent Developments
  • Table 55 : CRISPR Therapeutics: Product Portfolio
  • Table 56 : CRISPR Therapeutics: Recent Developments
  • Table 57 : Editas Medicine: Product Portfolio
  • Table 58 : Editas Medicine: Recent Developments
  • Table 59 : Genscript: Product Portfolio
  • Table 60 : Genscript: Recent Developments
  • Table 61 : Horizon Discovery: Product Portfolio
  • Table 62 : Horizon Discovery: Recent Developments
  • Table 63 : Integrated DNA Technologies (IDT): Product Portfolio
  • Table 64 : Integrated DNA Technologies (IDT): Recent Developments
  • Table 65 : Intellia Therapeutics Inc.: Product Portfolio
  • Table 66 : Intellia Therapeutics Inc.: Recent Developments
  • Table 67 : Lonza Group Ltd.: Product Portfolio
  • Table 68 : Lonza Group Ltd.: Recent Developments
  • Table 69 : New England Biolabs Inc.: Product Portfolio
  • Table 70 : New England Biolabs Inc.: Recent Developments
  • Table 71 : OriGene Technologies: Product Portfolio
  • Table 72 : Precision BioSciences: Product Portfolio
  • Table 73 : Precision BioSciences: Recent Developments
  • Table 74 : Sangamo Therapeutics Inc.: Product Portfolio
  • Table 75 : Sangamo Therapeutics Inc.: Recent Developments
  • Table 76 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 77 : Thermo Fisher Scientific Inc.: Recent Developments
  • Table 78 : Transposagenbio Biopharmaceuticals (Hera Biolabs): Product Portfolio
  • Table 79 : Transposagenbio Biopharmaceuticals (Hera Biolabs): Recent Developments

List of Figures

  • Summary Figure : Global Market for CRISPR Technology, by End User, 2017-2023
  • Figure 1 : Porter's Five Forces Model
  • Figure 2 : Patent Activity on CRISPR Technology, 2008-2018
  • Figure 3 : CRISPR Licensing Landscape
  • Figure 4 : NIH Funding for CRISPR Research, 2014-2018
  • Figure 5 : Global Market for CRISPR Technology, by End User, 2017-2023
  • Figure 6 : Global Market for CRISPR Technology, by Application, 2017-2023
  • Figure 7 : Global Market for CRISPR Technology, by Region, 2017-2023
目次
Product Code: HLC258A

Highlights:

The global market for CRISPR technology should grow from $75.0 billion in 2018 to $218.9 billion by 2023, at a compound annual growth rate (CAGR) of 23.9% for the period of 2018-2023.

Biotechnology companies market should grow from $24.9 billion in 2018 to $73.3 billion by 2023 at a CAGR of 24.1% through 2023.

Pharmaceutical companies market should grow from $17.0 billion in 2018 to $52.8 billion by 2023 at a CAGR of 25.4% through 2023.

Report Scope:

The scope of this report is broad, covering the applications of CRISPR in medicine, drug therapy and agriculture. The market for CRISPR technology is broken down by application and end user. Revenue forecasts from 2018-2023 are given for each end user category and application with estimated value derived from the revenue of the companies' total revenues.

This report also includes a discussion of the major players across each regional market for CRISPR technology with respect to prominent strategic initiatives. Further, it explains the main drivers and regional dynamics of the global market and current trends within the industry.

Report Includes:

  • 45 data tables and 35 additional tables
  • An overview of global CRISPR market, discussion on CRISPR interference technique and its potential application in alteration of germline in animal, human and other organisms
  • Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Explanation of the major drivers and regional dynamics of the global CRISPR market and evaluation of its current market size, and market forecast
  • Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
  • Information on congenital anomalies, its prevalence, causes and its relation to mortality rate
  • Knowledge about Cell Line Engineering, CRISPR Plasmid, Genetic Engineering, GRNA Database/Gene Library and Human Stem Cells
  • Insights into regulatory framework and investment analysis
  • Market share analysis of the leading suppliers of the industry and their detailed company profiles, including Caribou Biosciences, Genscript, Integrated DNA Technologies, Intellia Therapeutics Inc., Precision Biosciences, Sangamo Therapeutics Inc., and Thermo Fisher Scientific

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

  • CRISPR: Genetic Editing
  • Pros of Genetic Editing
  • CRISPR Development Phases
  • Discovery of CRISPR
  • Discovery of Cas9 and PAM
  • Hypothesis: Adaptive Immunity
  • Adaptive Immunity
  • Spacer Sequences: gRNAs
  • CRISPR Acts on DNA Targets
  • Cas9 Cleaves Target DNA
  • tracrRNA for Cas9 Systems
  • CRISPR Systems in Other Species
  • Cas9-Mediated Cleavage
  • CRISPR-Cas9: Genome Editing
  • Market Potential
  • Regulatory Framework
  • U.S. Regulation and Oversight
  • NIH Guidelines
  • U.S. FDA
  • Ethical Considerations
  • Regulatory Issues
  • Regulations of Human Germline Edits
  • Global Regulations
  • Porter's Five Forces Analysis
  • Patent Analysis
  • Overview of CRISPR Technology Intellectual Property (IP) and Licensing Structure
  • Industry Drivers
  • CRISPR versus Disease
  • Government Funding
  • CRISPR in Other Fields
  • Industry Restraints
  • Alternative Technologies
  • Industry Challenges
  • Patent Issues

Chapter 4 Industry Structure

  • Commercial Therapeutics
  • Correcting Genetic Errors
  • Microbes
  • Healthier Food

Chapter 5 Competitive Landscape

  • Cellectis
  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Sangamo Therapeutics

Chapter 6 Global Market for CRISPR Technology by End User

  • Academic Institutes
  • Research and Development Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies

Chapter 7 Global Market for CRISPR Technology by Application

  • Cell Line Engineering
  • CRISPR Plasmid
  • Genetic Engineering
  • GRNA Databases/Gene Libraries
  • Human Stem Cells

Chapter 8 Global Market for CRISPR Technology by Region

  • North America
  • U.S.
  • Europe
  • UK
  • Asia-Pacific
  • China
  • India
  • Rest of the World

Chapter 9 Company Profiles

  • CARIBOU BIOSCIENCES
  • CRISPR THERAPEUTICS
  • EDITAS MEDICINE
  • GENSCRIPT
  • HORIZON DISCOVERY PLC
  • INTEGRATED DNA TECHNOLOGIES
  • INTELLIA THERAPEUTICS INC.
  • LONZA GROUP LTD.
  • NEW ENGLAND BIOLABS INC.
  • ORIGENE TECHNOLOGIES
  • PRECISION BIOSCIENCES
  • SANGAMO THERAPEUTICS INC.
  • THERMO FISHER SCIENTIFIC
  • TRANSPOSAGENBIO BIOPHRAMACEUTICALS (HERA BIOLABS)
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.